- Home
- PASG vs CIF Comparison
PASG vs CIF Comparison
Compare PASG & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PASG | CIF |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 29.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PASG | CIF |
|---|---|---|
| Price | $4.08 | $1.63 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 129.1K | 60.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $1.57 |
| 52 Week High | $20.00 | $1.82 |
Technical Indicators
Market Signals| Indicator | PASG | CIF |
|---|---|---|
| Relative Strength Index (RSI) | 29.13 | 48.89 |
| Support Level | N/A | N/A |
| Resistance Level | $8.94 | $1.73 |
| Average True Range (ATR) | 0.61 | 0.02 |
| MACD | -0.31 | 0.00 |
| Stochastic Oscillator | 2.35 | 50.00 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income, but it may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment-grade corporate bonds, government securities and other securities. The portfolio includes Midstream, Financial Institutions, Energy, Cable TV, and Utilities.